Costs and outcomes of tuberculosis control in the Russian Federation: Retrospective cohort analysis

Health Policy and Planning

Volumn 21, Issue 5, 2006, Pages 353-364

  Atun, R A ^a   Samyshkin, Y ^a   Drobniewski, F ^b   Balabanova, Y ^b   Fedorin, I M ^c   Lord, J ^d   Coker, R J ^e  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

^d Natl Inst for Clinical Excellence   (United Kingdom)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Economic evaluation; Health systems; Russian Federation; Tuberculosis

Indexed keywords

ACUTE DISEASE; ADULT; ARTICLE; CHRONIC DISEASE; COHORT ANALYSIS; CONTROL SYSTEM; COST; COST BENEFIT ANALYSIS; DISEASE ACTIVITY; ECONOMIC EVALUATION; FEMALE; FOLLOW UP; HEALTH CARE; HEALTH CARE COST; HEALTH CARE SYSTEM; HOSPITAL CARE; HOSPITALIZATION; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; ORGANIZATION; OUTCOMES RESEARCH; POLICY; RETROSPECTIVE STUDY; RUSSIAN FEDERATION; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

ADULT; COHORT STUDIES; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; RETROSPECTIVE STUDIES; RUSSIA; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 33750138862     PISSN: 02681080     EISSN: 14602237     Source Type: Journal    
DOI: 10.1093/heapol/czl023     Document Type: Article

References (38)

1. Atun RA, Lennox-Chhugani N, Drobniewski F et al. 2004. A framework and toolkit for capturing the communicable disease programmes within health systems: tuberculosis control as an illustrative example. European Journal of Public Health 14: 267-73.
2. Atun RA, Samyshkin YA, Drobniewski F et al. 2005a. Health system barriers to sustainable tuberculosis control in the Russian Federation. Bulletin of the World Health Organization 83: 217-23.
3. Atun RA, Samyshkin YA, Drobniewski F et al. 2005b. Seasonal variation and hospital utilization for tuberculosis in Russia: hospitals as social care institutions. European Journal of Public Health 15: 350-4.
4. Atun RA, Samyshkin YA, Drobniewski F et al. 2005c. Social factors influencing hospital utilisation by tuberculosis patients in the Russian Federation: analysis of routinely collected data. International Journal of Tuberculosis and Lung Disease 9: 1140-6.
5. Atun RA, Baeza J, Drobniewski F et al. 2005d. Implementing WHO DOTS strategy in the Russian Federation: stakeholder attitudes. Health Policy 74: 122-32.
6. Atun RA, Lebcir R, Drobniewski F et al. 2005e. Impact of an effective multidrug resistant tuberculosis control programmes in the setting of an immature HIV epidemic: system dynamics simulation model. International Journal of STD and AIDS 16: 560-70.
7. Balabanova Y, Drobniewski F, Fedorin I et al. 2006. The Directly Observed Therapy Short-Course (DOTS) strategy in Samara Oblast, Russian Federation. Respiratory Research 7: 44.
8. Balabanova Y, Coker R, Fedorin I et al. 2005. Intra- and inter-observer agreement in chest X-ray interpretation amongst Russian physicians: implications for active screening for tuberculosis. British Medical Journal 331: 379-82.
9. Borgdorff MW, Floyd K, Broekmans JF. 2002. Interventions to reduce tuberculosis mortality and transmission in low-and middle-income countries. Bulletin of the World Health Organization 80: 217-27.
10. Coker RJ, Dimitrova B, Drobniewski F et al. 2003. Tuberculosis control in Samara Oblast, Russia: institutional and regulatory environment. International Journal of Tuberculosis and Lung Disease 7: 920-32.
11. Coker RJ, Dimitrova B, Drobniewski F et al. 2005. Health system frailties in tuberculosis service provision in Russia: an analysis through the lens of formal nutritional support. Public Health 119: 837-43.
12. Coker R, McKee M, Atun R et al. 2006. Risk factors for pulmonary tuberculosis in Samara, Russia: case-control study. British Medical Journal 332: 85-87.
13. Drobniewski F, Balabanova Y, Ruddy M et al. 2002. Rifampin-and multidrug-resistant tuberculosis in Russian civilians and prison inmates: dominance of the Beijing strain family. Emerging Infectious Diseases 8: 1320-26.
14. Drobniewski F, Balabanova Y, Coker R. 2004. Clinical features, diagnosis, and management of multiple drug-resistant tuberculosis since 2002. Current Opinion in Pulmonary Medicine 10: 211-17.
15. Dye C, Watt CJ, Bleed DM et al. 2005. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. Journal of the American Medical Association 293: 2767-75.
16. Elzinga G, Raviglione MC, Maher D. 2004. Scale up: meeting targets in global tuberculosis control. The Lancet 363: 814-19.
17. Floyd K, Wilkinson D, Gilks C. 1997. Comparison of cost effectiveness of directly observed treatment (DOT) and conventionally delivered treatment for tuberculosis: experience from rural South Africa. British Medical Journal 315: 1407-11.
18. Floyd K, Skeva J, Nyirenda T et al. 2003. Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Lilongwe District, Malawi. International Journal of Tuberculosis and Lung Disease 7: S29-S37.
19. Floyd K, Hutubessy R, Samyshkin Y et al. 2006. Health systems efficiency in the Russian Federation: tuberculosis control. Bulletin of the World Health Organization 84: 43-51.
20. Kaplan EL, Meier P. 1958. Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 53: 457-81.
21. Kherosheva T, Thorpe LE, Kiryanova E et al. 2003. Encouraging outcomes in the first year of a TB control demonstration program: Orel Oblast, Russia. International Journal of Tuberculosis and Lung Disease 7: 1045-51.
22. Lin DY. 2000. Linear regression analysis of censored medical costs. Biostatistics 1: 35-47.
23. Maher D, Mikulencak M. 1999. What is DOTS? A guide to understanding the WHO recommended tuberculosis control strategy known as DOTS. Geneva: World Health Organization. WHO/CDS/CPC/TB/99.270.
24. Mawer C, Ignatenko N, Wares D et al. 2001. Comparison of the effectiveness of WHO short-course chemotherapy and standard Russian antituberculous regimens in Tomsk, western Siberia. The Lancet 358: 445-9.
25. Ministry of Health, Russian Federation. 1995. On improvement of tuberculosis care to the population of the Russian Federation. Prikaz No. 324. Moscow: Ministry of Health of the Russian Federation.
26. Ministry of Health. 2002. Recording/reporting form number 47: Information on health facilities infrastructure. Moscow: Ministry of Health of the Russian Federation.
27. Ministry of Health. 2003. On improving tuberculosis control in the Russian Federation. Prikaz No. 109. Moscow: Ministry of Health of the Russian Federation. 21 March 2003.
28. Ministry of Health. 2004. On implementing of TB recording/ reporting documentation for tuberculosis monitoring. Prikaz No. 50. Moscow: Ministry of Health of the Russian Federation, Moscow, Russia. 13 February 2004.
29. Nganda B, Wang'ombe J, Floyd K. 2003. Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Machakos District, Kenya. International Journal of Tuberculosis and Lung Disease 7: S14-S20.
30. Okello D, Floyd K, Adatu F et al. 2003. Cost and cost-effectiveness of community-based care in rural Uganda. International Journal of Tuberculosis and Lung Disease 7: S72-S79.
31. Raikou M, McGuire A. 2004. Estimating medical care costs under conditions of censoring. Journal of Health Economics 23: 443-70.
32. Shilova M. 2001. Tuberculosis in Russia in year 2000. Moscow: Research Institute of Phthisiopulmonology, Moscow Medical Academy.
33. WHO. 1997. Treatment of tuberculosis: guidelines for national programmes. Geneva: World Health Organization.
34. WHO. 2002a. The global plan to stop tuberculosis. Geneva: World Health Organization.
35. WHO. 2002b. An expanded DOTS framework for effective tuberculosis control. Geneva: World Health Organization.
36. WHO. 2002c. Cost-effective TB control in the Russian Federation. Report of the second project workshop. St Petersburg, Russia, 18-20 June 2002. Geneva: Stop TB Department, World Health Organization.
37. WHO. 2003. Treatment of tuberculosis: guidelines for national programmes. 3rd Edition. Geneva: World Health Organization. WHO/CDS/TB/2003.313.
38. WHO. 2004. Global tuberculosis control: surveillance, planning, financing. WHO Report 2004. Geneva: World Health Organization.